Dougal McClean

Comparison of an everolimus-eluting bioresorbable scaffold with an everolimus-eluting metallic stent for the treatment of coronary artery stenosis (ABSORB II): a 3 year, randomised, controlled, single-blind, multicentre clinical trial

Patrick W. Serruys, Bernard Chevalier, Yohei Sotomi et al. · The Lancet · 2016 · 538 citations · Full text

Medicine, Cardiology, Surgery +17

Evaluation of the Second Generation of a Bioresorbable Everolimus-Eluting Vascular Scaffold for the Treatment of De Novo Coronary Artery Stenosis

Patrick W. Serruys, Yoshinobu Onuma, Dariusz Dudek et al. · Journal of the American College of Cardiology · 2011 · 525 citations

Medicine, Cardiology, Surgery +14

Evaluation of the Second Generation of a Bioresorbable Everolimus Drug-Eluting Vascular Scaffold for Treatment of De Novo Coronary Artery Stenosis

Patrick W. Serruys, Yoshinobu Onuma, John A. Ormiston et al. · Circulation · 2010 · 306 citations · Full text

Medicine, Bioengineering, Cardiology +17

Botulinum toxin A in the hemiplegia upper limb: a double‐blind trial

I. S. Corry, A P. Cosgroce, E G Walsh et al. · Developmental Medicine & Child Neurology · 1997 · 281 citations · Full text

Medicine, Neurology, Rehabilitation Medicine +13

Dynamics of vessel wall changes following the implantation of the Absorb everolimus-eluting bioresorbable vascular scaffold: a multi-imaging modality study at 6, 12, 24 and 36 months

Patrick W. Serruys, Yoshinobu Onuma, Héctor M. García‐García et al. · EuroIntervention · 2014 · 238 citations · Full text

Medicine, Cardiology, Surgery +17